Disclaimer: At UPMC HealthBeat, we strive to provide the most up-to-date facts in our stories when we publish them. We also make updates to our content as information changes. However, education about COVID-19 can shift quickly based on new data, emerging variants, or other factors. The information in this story was accurate as of its publish date. We also encourage you to visit other reliable websites for updated information, including the Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and your state and local governments.
Messenger RNA, or mRNA, is a type of RNA found in your cells. It carries the genetic information needed to make proteins.
mRNA has become more widely discussed during the COVID-19 pandemic because of vaccines. The COVID-19 vaccines produced by Pfizer-BioNTech and Moderna both use mRNA technology to fight COVID-19.
In December 2020, the U.S. Food and Drug Administration (FDA) issued emergency use authorization for the Pfizer and Moderna COVID-19 vaccines. They became the first-ever mRNA-based vaccines to gain regulatory authorization.
In August 2021, the FDA approved the Pfizer vaccine — making it the first mRNA vaccine ever to receive full FDA approval. The FDA later approved the Moderna vaccine.
The mRNA vaccines have been an important tool in preventing COVID-19 cases and severe outcomes like hospitalizations and deaths. But what is mRNA, and what makes vaccines that use this molecule different?
Never Miss a Beat!
Subscribe to Our HealthBeat Newsletter!
Thank you for subscribing!
You are already subscribed.
Sorry, an error occurred. Please try again later.
Get Healthy Tips Sent to Your Phone!
What Is mRNA?
mRNA stands for messenger ribonucleic acid. They’re single-stranded molecules that carry genetic code from DNA in a cell’s nucleus to ribosomes, which make protein in the cells. These molecules are called messenger RNA because they carry instructions for producing proteins from one part of the cell to another.
How mRNA delivers messages in three steps:
- A process known as transcription makes an RNA copy of a DNA sequence for a protein.
- This copy, known as mRNA, moves from the nucleus (center) of the cell to the ribosomes. Ribosomes, which are located in the cell outside of the nucleus, make proteins.
- Ribosomes “translate” the instructions in mRNA and synthesize the protein.
How Does an mRNA Vaccine Work?
mRNA vaccines work differently than traditional vaccines because they do not use a live virus. Instead, they use mRNA created in a laboratory that corresponds to a protein, or part of a protein, from a virus. The vaccine teaches our cells how to make that protein, triggering an immune response that produces antibodies.
For COVID-19, scientists engineered a synthetic mRNA that codes for the spike protein on SARS-CoV-2 — the novel coronavirus that causes COVID-19. This is the part of the virus that helps it enter human cells. The spikes are what you see on illustrations of the SARS-CoV-2 viral particle.
The synthetic mRNA in the vaccine instructs cells in the human body to make their own viral spike protein. This triggers the immune system to make antibodies to fight the virus. Once the immune system knows how to make these antibodies, it can do it again when exposed to the spike protein.
You can think of an mRNA vaccine as sending instructions into the body on how to fight COVID-19. Once the body makes the viral proteins, the immune system learns how to destroy them. This gives your body the tools to defend against SARS-CoV-2 if you’re exposed.
Lipid nanoparticles are necessary in the manufacture of mRNA vaccines. Scientists encase mRNA inside a pod made of oily lipids, which allow mRNA to more easily slide into cells.
How Are mRNA Vaccines Different Than Traditional Vaccines?
The goal of any vaccine is to train your body to recognize and fight germs by producing antibodies and activating immune cells.
Conventional vaccines introduce weakened, dead, or noninfectious parts of a virus or bacterium to the body. By contrast, mRNA vaccines give the body instructions for making its own viral or bacterial proteins. The immune system then responds by creating antibodies.
Benefits of mRNA vaccines to traditional vaccines
- There is no risk of infection by the vaccine because mRNA vaccines do not introduce a live virus to the body.
- Unlike conventional vaccines, mRNA vaccines are not grown in live cells. This can speed up the manufacturing process. mRNA vaccines also bypass the step of inactivating viruses or isolating the protein, which also makes them quicker to produce.
- mRNA vaccines are more effective against germs that evolve through mutation. That’s because RNA vaccines typically trigger an immune response to a part of the virus (the viral stalk) that doesn’t mutate easily. Traditional vaccines typically target a different part of the virus (the globular head), which does mutate easily.
Who Can Get an mRNA COVID-19 Vaccine?
The FDA has authorized the Pfizer and Moderna vaccines in Americans 6 months and up. The initial vaccination series calls for two doses over a multi-week span, with different dosages depending on your age. Many Americans are eligible for additional or booster doses in the months after they receive their initial vaccination doses.
For more information on COVID-19 vaccination, visit our website.
Editor's Note: This article was originally published on , and was last reviewed on .
The Science and Fundamentals of mRNA Technology. Moderna. Link
Why so many people are hopeful about an mRNA coronavirus vaccine. CNBC. Link
Moderna's mRNA vaccine reaches its final phase. Here's how it works. National Geographic. Link
Vaccine Chaos Is Looming. The Atlantic. Link
Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study. Pfizer. Link
How Scientists Could Stop the Next Pandemic Before It Starts. The New York Times. Link
Candidate for universal flu vaccine protects against multiple strains. Science Daily. Link
Headquartered in Pittsburgh, UPMC is a world-renowned health care provider and insurer. We operate 40 hospitals and 800 doctors’ offices and outpatient centers, with locations throughout Pennsylvania, Maryland, New York, West Virginia, and internationally. We employ 4,900 physicians, and we are leaders in clinical care, groundbreaking research, and treatment breakthroughs. U.S. News & World Report consistently ranks UPMC Presbyterian Shadyside as one of the nation’s best hospitals in many specialties and ranks UPMC Children’s Hospital of Pittsburgh on its Honor Roll of America’s Best Children’s Hospitals. We are dedicated to providing Life Changing Medicine to our communities.